Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
Cancer and Metastasis Reviews · 2024
DOI: 10.1007/s10555-024-10177-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, 2024. Verfasst von Shabnam Malik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, School of Medicine, Biomedical Research Building, University of Texas Rio Grande Valley, 5300 North L Stre…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Cell Plasticity, Mucins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, USA NIH.
Abstract (Originalsprache)
There has been a surge of interest in recent years in understanding the intricate mechanisms underlying cancer progression and treatment resistance. One molecule that has recently emerged in these mechanisms is MUC13 mucin, a transmembrane glycoprotein. Researchers have begun to unravel the molecular complexity of MUC13 and its impact on cancer biology. Studies have shown that MUC13 overexpression can disrupt normal cellular polarity, leading to the acquisition of malignant traits. Furthermore, MUC13 has been associated with increased cancer plasticity, allowing cells to undergo epithelial-mesenchymal transition (EMT) and metastasize. Notably, MUC13 has also been implicated in the development of chemoresistance, rendering cancer cells less responsive to traditional treatment options. Understanding the precise role of MUC13 in cellular plasticity, and chemoresistance could pave the way for the development of targeted therapies to combat cancer progression and enhance treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, School of Medicine, Biomedical Research Building, University of Texas Rio Grande Valley, 5300 North L Street, McAllen, TX, 78504, USA.
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
- Unit of Research and Scientific Studies, College of Nursing and Allied Health Sciences, University of Jazan, Jizan, Saudi Arabia.
- Amity Institute of Pharmacy, Amity University, Uttar Pradesh, Noida, India.
- Department of Medicine, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
- Department of Immunology and Microbiology, School of Medicine, Biomedical Research Building, University of Texas Rio Grande Valley, 5300 North L Street, McAllen, TX, 78504, USA. Subhash.Chauhan@utrgv.edu.
ORCID-Profile: Subhash C Chauhan
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- USA NIH
Zitieren
APA
Malik, S., Sikander, M., Wahid, M., Dhasmana, A., Sarwat, M., Khan, S., Cobos, E., Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2024). Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-024-10177-8
Vancouver
Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, et al. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer and Metastasis Reviews. 2024. doi:10.1007/s10555-024-10177-8
BibTeX
@article{Malik2024,
author = {Malik, Shabnam and Sikander, Mohammed and Wahid, Mohd and Dhasmana, Anupam and Sarwat, Maryam and Khan, Sheema and Cobos, Everardo and Yallapu, Murali M and Jaggi, Meena and Chauhan, Subhash C},
title = {Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance},
journal = {Cancer and Metastasis Reviews},
year = {2024},
doi = {10.1007/s10555-024-10177-8}
}
EUVIMED